Phase I trials may not need to be viewed as extraordinarily different from other clinical research
- PMID: 17008685
- DOI: 10.1200/JCO.2006.08.1182
Phase I trials may not need to be viewed as extraordinarily different from other clinical research
Comment on
-
Rethinking risk-benefit assessment for phase I cancer trials.J Clin Oncol. 2006 Jul 1;24(19):2987-90. doi: 10.1200/JCO.2005.04.9296. J Clin Oncol. 2006. PMID: 16809725 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
